@article{ATM3203,
author = {Jeong Seon Ryu and Azra Memon and Seul-Ki Lee},
title = {ERCC1 and personalized medicine in lung cancer},
journal = {Annals of Translational Medicine},
volume = {2},
number = {4},
year = {2014},
keywords = {},
abstract = {Excision repair cross-complementing group 1 (ERCC1) is known to be a key player in nucleotide excision repair (NER) pathway. Its prognostic or predictive relevance has been extensively investigated in cancer patients including non-small-cell lung cancer. However, several questions should be addressed before its clinical application as biomarker for patient classification or guiding platinum treatment.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/3203}
}